In this study, a 365-liver hepatocellular carcinoma (LIHC) cohort from the TCGA dataset and a retrospective HCC cohort from Zhuhai People’s Hospital were enrolled to explore effect of FDX1 expression on patient survival with HCC. This evidence concerns the gene FDX1 and hepatocellular carcinoma.